157 related articles for article (PubMed ID: 26574608)
21. [Characterization of mutational pattern in patients with Ph negative myeloproliferative neoplasms].
Xing F; Lin YN; Sun Q; Qin L; Jia YJ; Zhang DL; Ru K
Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):626-30. PubMed ID: 27646892
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the oxygen sensing pathway genes in familial chronic myeloproliferative neoplasms and identification of a novel EGLN1 germ-line mutation.
Albiero E; Ruggeri M; Fortuna S; Bernardi M; Finotto S; Madeo D; Rodeghiero F
Br J Haematol; 2011 May; 153(3):405-8. PubMed ID: 21275967
[No Abstract] [Full Text] [Related]
23. Genetics: Myeloproliferative neoplasms—order of mutations counts!
Hutchinson L
Nat Rev Clin Oncol; 2015 Apr; 12(4):187. PubMed ID: 25734632
[No Abstract] [Full Text] [Related]
24. LNK mutations in familial myeloproliferative neoplasms.
Rumi E; Harutyunyan AS; Pietra D; Feenstra JD; Cavalloni C; Roncoroni E; Casetti I; Bellini M; Milanesi C; Renna MC; Gotti M; Astori C; Kralovics R; Cazzola M
Blood; 2016 Jul; 128(1):144-5. PubMed ID: 27216218
[No Abstract] [Full Text] [Related]
25. The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms.
Oddsson A; Kristinsson SY; Helgason H; Gudbjartsson DF; Masson G; Sigurdsson A; Jonasdottir A; Jonasdottir A; Steingrimsdottir H; Vidarsson B; Reykdal S; Eyjolfsson GI; Olafsson I; Onundarson PT; Runarsson G; Sigurdardottir O; Kong A; Rafnar T; Sulem P; Thorsteinsdottir U; Stefansson K
Leukemia; 2014 Jun; 28(6):1371-4. PubMed ID: 24476768
[No Abstract] [Full Text] [Related]
26. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
[TBL] [Abstract][Full Text] [Related]
27. The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms.
Meggendorfer M; Jeromin S; Haferlach C; Kern W; Haferlach T
Haematologica; 2018 May; 103(5):e192-e195. PubMed ID: 29700173
[No Abstract] [Full Text] [Related]
28. NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F; Paolini A; Morselli M; Bigliardi S; Bonacorsi G; Leonardi G; Coluccio V; Maccaferri M; Fantuzzi V; Faglioni L; Colaci E; Soci F; Nasillo V; Messerotti A; Arletti L; Pioli V; Zucchini P; Quadrelli C; Corradini G; Giacobbi F; Vallerini D; Riva G; Barozzi P; Lagreca I; Marasca R; Narni F; Mecucci C; Ottaviani E; Martinelli G; Falini B; Luppi M; Potenza L
Leuk Lymphoma; 2015; 56(11):3222-6. PubMed ID: 25813079
[No Abstract] [Full Text] [Related]
29. Screening families with endometrial and colorectal cancers for germline mutations.
Liu T; Chen J; Salahshor S; Kuismanen S; Holmberg E; Grönberg H; Peltomäki P; Lindblom A
J Med Genet; 2001 Sep; 38(9):E29. PubMed ID: 11546830
[No Abstract] [Full Text] [Related]
30. TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm.
Beird H; Yin CC; Khoury JD; Pierce S; Abbas HA; Zhao L; Skwarska A; Qazilbash M; Konopleva M; Futreal PA; Pemmaraju N
Blood Adv; 2023 May; 7(10):2000-2003. PubMed ID: 36689729
[No Abstract] [Full Text] [Related]
31. ATM germline mutations in women with familial breast cancer and a relative with haematological malignancy.
Paglia LL; Laugé A; Weber J; Champ J; Cavaciuti E; Russo A; Viovy JL; Stoppa-Lyonnet D
Breast Cancer Res Treat; 2010 Jan; 119(2):443-52. PubMed ID: 19404735
[TBL] [Abstract][Full Text] [Related]
32. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
[TBL] [Abstract][Full Text] [Related]
33. Germ line predisposition to myeloid malignancies appearing in adulthood.
Crysandt M; Brings K; Beier F; Thiede C; Brümmendorf TH; Jost E
Expert Rev Hematol; 2018 Aug; 11(8):625-636. PubMed ID: 29958021
[TBL] [Abstract][Full Text] [Related]
34. Effect of mutation order on myeloproliferative neoplasms.
Delhommeau F
N Engl J Med; 2015 May; 372(19):1865. PubMed ID: 25946290
[No Abstract] [Full Text] [Related]
35. Effect of mutation order on myeloproliferative neoplasms.
Kent DG; Ortmann CA; Green AR
N Engl J Med; 2015 May; 372(19):1865-6. PubMed ID: 25946289
[No Abstract] [Full Text] [Related]
36. Germline mosaicism of a novel UBE3A mutation in Angelman syndrome.
Hosoki K; Takano K; Sudo A; Tanaka S; Saitoh S
Am J Med Genet A; 2005 Oct; 138A(2):187-9. PubMed ID: 16100729
[No Abstract] [Full Text] [Related]
37. [JAK2 mutation and thrombosis - recommendations for screening].
Held M
Dtsch Med Wochenschr; 2012 Feb; 137(5):227. PubMed ID: 22278696
[No Abstract] [Full Text] [Related]
38. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis and association of RBBP6 with apoptosis in colon cancers.
Dlamini Z; Rupnarain C; Naicker S; Hull R; Mbita Z
J Mol Histol; 2016 Apr; 47(2):169-82. PubMed ID: 26905308
[TBL] [Abstract][Full Text] [Related]
40. Familial uveal melanoma: absence of germline mutations involving the cyclin-dependent kinase-4 inhibitor gene (p16).
Singh AD; Croce CM; Wary KK; Shields JA; Donoso LA; Shields CL; Huebner K; Ohta M
Ophthalmic Genet; 1996 Mar; 17(1):39-40. PubMed ID: 8740697
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
